Literature DB >> 18508487

Renin and prorenin disappearance in humans post-nephrectomy: evidence for binding?

Manne Krop1, Jan H B de Bruyn, Frans H M Derkx, Alexander H J Danser.   

Abstract

To study the distribution of kidney-derived renin-angiotensin system (RAS) components in humans, we monitored the decline in plasma prorenin, renin, angiotensin (Ang) I and Ang II post-nephrectomy. Prorenin and renin decreased biphasically, prorenin displaying a slower elimination. The distribution half life was similar for both. Angiotensins followed the disappearance of renin. One-two days post-nephrectomy, stable plasma concentrations at 5-10% (renin and angiotensins) and 25-30% (prorenin) of pre-nephrectomy levels were reached. The total amount of kidney-derived renin and prorenin in the body was approximately 10 times as much as the amount in blood. Prorenin also originated at extrarenal sites. The renin levels in anephrics corresponded with the percentage of prorenin that in vitro has a so-called 'open conformation' (i.e., displays enzymatic activity), suggesting that renin in anephrics is in fact 'open' prorenin. Haemodialysis nor captopril significantly affected the level of any RAS component in anephrics. In conclusion, renal renin/prorenin enter tissue sites in humans, and renal renin is the main determinant of plasma angiotensins. Whether prorenin contributes to tissue angiotensin generation in humans remains to be determined.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18508487     DOI: 10.2741/2981

Source DB:  PubMed          Journal:  Front Biosci        ISSN: 1093-4715


  10 in total

1.  Renin and cardiovascular disease: Worn-out path, or new direction.

Authors:  Gaurav Alreja; Jacob Joseph
Journal:  World J Cardiol       Date:  2011-03-26

2.  Differential regulation of angiotensin-(1-12) in plasma and cardiac tissue in response to bilateral nephrectomy.

Authors:  Carlos M Ferrario; Jasmina Varagic; Javad Habibi; Sayaka Nagata; Johji Kato; Mark C Chappell; Aaron J Trask; Kazuo Kitamura; Adam Whaley-Connell; James R Sowers
Journal:  Am J Physiol Heart Circ Physiol       Date:  2009-02-13       Impact factor: 4.733

Review 3.  Urinary markers of intrarenal renin-angiotensin system activity in vivo.

Authors:  Lodi C W Roksnoer; Koen Verdonk; Anton H van den Meiracker; Ewout J Hoorn; Robert Zietse; A H Jan Danser
Journal:  Curr Hypertens Rep       Date:  2013-04       Impact factor: 5.369

4.  Intrarenal renin-angiotensin system activity is augmented after initiation of dialysis.

Authors:  Naro Ohashi; Shinsuke Isobe; Sayaka Ishigaki; Takahisa Suzuki; Masafumi Ono; Tomoyuki Fujikura; Takayuki Tsuji; Akihiko Kato; Seiichiro Ozono; Hideo Yasuda
Journal:  Hypertens Res       Date:  2016-10-20       Impact factor: 3.872

5.  Longitudinal Changes in Prorenin and Renin in the Chronic Renal Insufficiency Cohort.

Authors:  Monique E Cho; Carol Sweeney; Nora Fino; Tom Greene; Nirupama Ramkumar; Yufeng Huang; Ana C Ricardo; Tariq Shafi; Rajat Deo; Amanda Anderson; Katherine T Mills; Alfred K Cheung
Journal:  Am J Nephrol       Date:  2021-03-18       Impact factor: 3.754

Review 6.  The (pro)renin receptor. A decade of research: what have we learned?

Authors:  Manne Krop; Xifeng Lu; A H Jan Danser; Marcel E Meima
Journal:  Pflugers Arch       Date:  2012-04-28       Impact factor: 3.657

Review 7.  Juxtaglomerular Cell Phenotypic Plasticity.

Authors:  Alexandre Góes Martini; A H Jan Danser
Journal:  High Blood Press Cardiovasc Prev       Date:  2017-05-19

8.  A detailed physiologically based model to simulate the pharmacokinetics and hormonal pharmacodynamics of enalapril on the circulating endocrine Renin-Angiotensin-aldosterone system.

Authors:  Karina Claassen; Stefan Willmann; Thomas Eissing; Tobias Preusser; Michael Block
Journal:  Front Physiol       Date:  2013-02-08       Impact factor: 4.566

Review 9.  Prorenin anno 2008.

Authors:  A H Jan Danser; Wendy W Batenburg; Joep H M van Esch; Manne Krop
Journal:  J Mol Med (Berl)       Date:  2008-03-06       Impact factor: 4.599

10.  Monocytic angiotensin-converting enzyme 2 relates to atherosclerosis in patients with chronic kidney disease.

Authors:  Bogusz Trojanowicz; Christof Ulrich; Felix Kohler; Veronika Bode; Eric Seibert; Roman Fiedler; Matthias Girndt
Journal:  Nephrol Dial Transplant       Date:  2017-02-01       Impact factor: 5.992

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.